|
1
|
Diamandis P and Aldape K: World Health
Organization 2016 Classification of Central Nervous System Tumors.
Neurol Clin. 36:439–447. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi J, Dong B, Cao J, Mao Y, Guan W, Peng
Y and Wang S: Long non-coding RNA in glioma: Signaling pathways.
Oncotarget. 8:27582–27592. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cloughesy TF, Cavenee WK and Mischel PS:
Glioblastoma: From molecular pathology to targeted treatment. Annu
Rev Pathol. 9:1–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olar A and Aldape KD: Using the molecular
classification of glioblastoma to inform personalized treatment. J
Pathol. 232:165–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu L, Ma R, Wang Y and Nishino H: Potent
anti-tumor activity and low toxicity of tubeimoside 1 isolated from
Bolbostemma paniculatum. Planta Med. 60:204–208. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang XH, Sun NX, Guo RX, Xing JL and Liu
XN: Efficacy research of tubeimoside against the experimental
herpes simplex keratitis. Rec Adv Ophthalmol. 22:373–376. 2002.
|
|
7
|
He D, Huang B, Fu S, Li Y, Ran X, Liu Y,
Chen G, Liu J, Liu D and Tubeimoside I: Tubeimoside I protects
dopaminergic neurons against inflammation-mediated damage in
lipopolysaccharide (LPS)-evoked model of Parkinson's disease in
rats. Int J Mol Sci. 19:E22422018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Islam MS, Wang C, Zheng J, Paudyal N, Zhu
Y and Sun H: The potential role of tubeimosides in cancer
prevention and treatment. Eur J Med Chem. 162:109–121. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jia G, Wang Q, Wang R, Deng D, Xue L, Shao
N, Zhang Y, Xia X, Zhi F and Yang Y: Tubeimoside-1 induces glioma
apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome
C/Caspase-3 pathway. Onco Targets Ther. 8:303–311. 2015.PubMed/NCBI
|
|
10
|
Wu T, Cui H, Xu Y, Du Q, Zhao E, Cao J,
Nie L, Fu G and Ren A: The effect of tubeimoside-1 on the
proliferation, metastasis and apoptosis of oral squamous cell
carcinoma in vitro. OncoTargets Ther. 11:3989–4000. 2018.
View Article : Google Scholar
|
|
11
|
Jiang SL, Guan YD, Chen XS, Ge P, Wang XL,
Lao YZ, Xiao SS, Zhang Y, Yang JM, Xu XJ, et al: Tubeimoside-1, a
triterpenoid saponin, induces cytoprotective autophagy in human
breast cancer cells in vitro via Akt-mediated pathway. Acta
Pharmacol Sin. 40:919–928. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baryawno N, Sveinbjörnsson B, Eksborg S,
Chen CS, Kogner P and Johnsen JI: Small-molecule inhibitors of
phosphatidylinositol 3-kinase/Akt signaling inhibit
Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma
growth. Cancer Res. 70:266–276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi H, Bi H, Sun X, Dong H, Jiang Y, Mu H,
Li W, Liu G, Gao R and Su J: Tubeimoside-1 inhibits the
proliferation and metastasis by promoting miR-126-5p expression in
non-small cell lung cancer cells. Oncol Lett. 16:3126–3134.
2018.PubMed/NCBI
|
|
14
|
Srivastav AK, Dubey D, Chopra D, Singh J,
Negi S, Mujtaba SF, Dwivedi A and Ray RS: Oxidative stress-mediated
photoactivation of carbazole inhibits human skin cell physiology. J
Cell Biochem. 121:1273–1282. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grier JT and Batchelor T: Low-grade
gliomas in adults. Oncologist. 11:681–693. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bush NA, Chang SM and Berger MS: Current
and future strategies for treatment of glioma. Neurosurg Rev.
40:1–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Gao W, Zhang L, Zhang D, Zhao Z
and Bao Y: Deoxypodophyllotoxin inhibits cell viability and
invasion by blocking the PI3K/Akt signaling pathway in human
glioblastoma cells. Oncol Rep. 41:2453–2463. 2019.PubMed/NCBI
|
|
18
|
Ebrahimi S, Hosseini M, Shahidsales S,
Maftouh M, Ferns GA, Ghayour-Mobarhan M, Hassanian SM and Avan A:
Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic
Strategy for the Treatment of Pancreatic Cancer. Curr Med Chem.
24:1321–1331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Q, Jiang W and Hou P: Emerging role
of PI3K/AKT in tumor-related epigenetic regulation. Semin Cancer
Biol pii. S1044-579X(18)30136-6. 2019. View Article : Google Scholar
|
|
20
|
Fleischer A, Ghadiri A, Dessauge F,
Duhamel M, Rebollo MP, Alvarez-Franco F and Rebollo A: Modulating
apoptosis as a target for effective therapy. Mol Immunol.
43:1065–1079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Wu C, Chen N, Gu H, Yen A, Cao L,
Wang E and Wang L: PI3K/Akt/mTOR signaling pathway and targeted
therapy for glioblastoma. Oncotarget. 7:33440–33450. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parsons DW, Jones S, Zhang X, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et
al: An integrated genomic analysis of human glioblastoma
multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wiman KG and Zhivotovsky B: Understanding
cell cycle and cell death regulation provides novel weapons against
human diseases. J Intern Med. 281:483–495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arellano M and Moreno S: Regulation of
CDK/cyclin complexes during the cell cycle. Int J Biochem Cell
Biol. 29:559–573. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang R, Yi L, Dong Z, Ouyang Q, Zhou J,
Pang Y, Wu Y, Xu L and Cui H: Tigecycline inhibits glioma growth by
regulating miRNA-199b-5p-HES1-AKT pathway. Mol Cancer Ther.
15:421–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Robertson JD and Orrenius S: Molecular
mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev
Toxicol. 30:609–627. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Creagh EM: Caspase crosstalk: Integration
of apoptotic and innate immune signalling pathways. Trends Immunol.
35:631–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kvansakul M and Hinds MG: Structural
biology of the Bcl-2 family and its mimicry by viral proteins. Cell
Death Dis. 4:e9092013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Soriano ME and Scorrano L: The interplay
between BCL-2 family proteins and mitochondrial morphology in the
regulation of apoptosis. Adv Exp Med Biol. 687:97–114. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Forbes-Hernández TY, Giampieri F,
Gasparrini M, Mazzoni L, Quiles JL, Alvarez-Suarez JM and Battino
M: The effects of bioactive compounds from plant foods on
mitochondrial function: A focus on apoptotic mechanisms. Food Chem
Toxicol. 68:154–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Palmer CS, Osellame LD, Stojanovski D and
Ryan MT: The regulation of mitochondrial morphology: Intricate
mechanisms and dynamic machinery. Cell Signal. 23:1534–1545. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Xu X and He P: Tubeimoside-1
inhibits proliferation and induces apoptosis by increasing the Bax
to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549
cells. Mol Med Rep. 4:25–29. 2011.PubMed/NCBI
|
|
35
|
Chen WJ, Yu C, Yang Z, He JL, Yin J, Liu
HZ, Liu HT and Wang YX: Tubeimoside-1 induces G2/M phase arrest and
apoptosis in SKOV-3 cells through increase of intracellular
Ca2+ and caspase-dependent signaling pathways. Int J
Oncol. 40:535–543. 2012.PubMed/NCBI
|
|
36
|
Chao Y, Wang Y, Liu X, Ma P, Shi Y, Gao J,
Shi Q, Hu J, Yu R and Zhou X: Mst1 regulates glioma cell
proliferation via the AKT/mTOR signaling pathway. J Neurooncol.
121:279–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
